A Multi-Centre Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors

Trial Profile

A Multi-Centre Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors

Recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs Concizumab (Primary) ; Turoctocog alfa
  • Indications Haemophilia A
  • Focus Therapeutic Use
  • Acronyms Explorer 5
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 25 Aug 2017 Planned End Date changed from 8 Aug 2019 to 9 Aug 2019.
    • 17 Aug 2017 Status changed from not yet recruiting to recruiting.
    • 02 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top